The University of Arizona

Simtuzumab (GS-6624)

Summary: 

This study is to evaluate the efficacy and safety of simtuzumab (GS-6624) in adults with idiopathic pulmonary fibrosis.

Sponsor: 
Gilead Sciences

Researchers: 

Research Specialties: 
Pulmonary